MAGNETIC RESONANCE SPECTROSCOPY IN EVALUATION OF COGNITIVE FUNCTIONS IN PATIENTS WITH METABOLIC SYNDROME
https://doi.org/10.18705/1607-419X-2013-19-1-51-58
Abstract
Objective. To evaluate the role of magnetic resonance spectroscopy (MR-spectroscopy) in the study of cognitive functions in patients with metabolic syndrome (MS).
Design and methods. The study included patients with MS (10 patients without cognitive impairment and 11 subjects with cognitive dysfunction). All patients underwent neuropsychological testing, and cognitive evoked potential for the assessment of cognitive functions. Brain metabolism was studied by proton MR-spectroscopy.
Results. In patients with MS and cognitive impairment, and without cognitive dysfunction no morphological changes in the brain according to the magnetic resonance imaging (MRI) were found. According to MR-spectroscopy of the brain in patients with MS and cognitive dysfunction the metabolism impairment is primarily associated with the increase in lactate and inositol.
Conclusion. Indicators of neuropsychological testing, the cognitive evoked potential are associated with the violation of brain metabolism in patients with MS and cognitive impairment.
About the Authors
I. B. Zueva
Almazov Federal Heart, Blood, and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
Corresponding author: Almazov Federal Heart, Blood and Endocrinology Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. Phone: 8 (812) 496–86–00. E-mail: iravit@yandex.ru (Irina B. Zueva, MD, PhD, the Head of the Cardiology Department № 1 for the Patients with Acute Myocardial Infarction at Almazov Federal Heart, Blood and Endocrinology Centre).
N. V. Moroshkina
Almazov Federal Heart, Blood, and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
E. R. Barantsevich
Almazov Federal Heart, Blood, and Endocrinology Centre, St Petersburg;
Pavlov St Petersburg State Medical University, St Petersburg
Russian Federation
Russian Federation
G. E. Trufanov
Military Medical Academy named after S.M. Kirov, St Petersburg
Russian Federation
Russian Federation
References
1. Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте // Методическое пособие для врачей. — М., 2005. — 71 с. / Zakharov V.V., Yakhno N.N. Cognitive disorders in elderly and senile age // The textbook for physicians. — Moscow, 2005. — 71 p. [Russian].
2. Зуева И.Б., Ванаева К.И., Санец Е.Л. и др. Взаимосвязь факторов сердечно-сосудистого риска с когнитивными функциями у пациентов среднего возраста // Артериальная гипертензия. — 2011. — Т. 17, № 5. — С. 432–441. / Zueva I.B., Vanaeva K.I., Sanez E.L. et al. Association of cognitive function with cardiovascular risk factors in middle age individuals // Arterial Hypertension [Arterialnaya Gipertenziya]. — 2011. — Vol. 17, № 5. — Р. 432–440 [Russian].
3. Farias S.T., Mungas D., Reed B.R., Harvey D., DeCarli C. Neuropsychological assessment in the diagnosis of Alzheimer’s disease // Arch. Neurol. — 2009. — Vol. 66, № 9. — Р. 1151–1157.
4. Поздняков А.В. Роль протонной магнитно-резонансной спектроскопии в диагностике заболеваний головного мозга // Дис. … д-ра мед. наук. — СПб., 2001. — 246 с. / Pozdnyakov A.V. The role of proton magnetic resonance spectroscopy in the diagnosis of diseases of the brain // Dis. Dr. med. sciences. — St Petersburg, 2001. — 246 p. [Russian].
5. Ринк П.А. Магнитный резонанс в медицине. — М.: ГЭОТАР-МЕД, 2003. — 256 с. / Pink P.A. Magnetic resonance in medicine. — Moscow: GAOTAR-MED, 2003. — 256 p. [Russian].
6. Andreana P., Haley D., Tarumi T., Gonzales M.M., Suwagara J., Tanaka H. Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: A H MRS Study // Brain Res. — 2010. — Vol. 1344. — P. 54–61.
7. Danielsen E.R., Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. — New York: Dekker, Marcel Inc., 1999.
8. Barker P.B., Gillard J.H., van Zijl P.C. et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging // Radiology. — 1994. — Vol. 192, № 3. — P. 723–732.
9. MacKay S., Meyerhoff D.J., Constans J.M., Norman D., Fein G., Weiner M.W. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with H magnetic resonance spectroscopic imaging // Arch. Neurol. — 1996. — Vol. 53, № 2. — Р. 167–174.
10. Ben Salem D., Walker P.M., Bejot Y. et al. N-acetylas-partate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly // Hypertens. Res. — 2008. — Vol. 31, № 10. — P. 1851–1857.
11. Haley A.P., Gunstad J., Cohen R.A., Jerskey B.A., Mulligan R.C., Sweet LH. Neural correlates of visuospatial working memory in healthy young adults at risk for hypertension // Brain Imaging Behav. — 2008. — Vol. 2. — P. 192–199.
12. Sachdev P., Chen X., Wen W. White matter hyperintensities in mid-adult life // Curr. Opin. Psychiatry. — 2008. — Vol. 21, № 3. — P. 268–274.
13. Summerfeld C., Gomez-Anson B., Tolosa E. et al. Dementia in Parkinson’s disease: a proton magnetic resonance spectroscopy study // Arch. Neurol. — 2002. — Vol. 59, № 9. — P. 1415–1420.
14. Grieve S.M., Williams L.M., Paul R.H., Clark C.R., Gordon E. Cognitive aging, executive function, and fractional anisotrophy: a diffusion tensor MRI study // Am. J. Neuroradiol. — 2007. — Vol. 28, № 2. — P. 226–235.
15. Schiavene F., Charlton R.A., Barrick T.R., Morris R.G., Markus H.S. Imaging age-related cognitive decline: a comparison of diffusion tensor and magnetization transfer MRI // J. Magn. Reson. Imaging. — 2009. — Vol. 29, № 1. — P. 23–30.
16. Selkoe D.J. Alzheimer’s Disease is a synaptic failure // Science. — 2002. — Vol. 298, № 5594. — P. 789–791.
17. Coleman P., Federoff H., Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementia // Neurology. — 2004. — Vol. 63, № 7. — P. 1155–1162.
18. Sitburana O., Ondo W.G. Brain magnetic resonance imaging in parkinsonian disorders // Parkinsonism Relat. Disord. — 2009. — Vol. 15, № 3. — P.165–174.
19. Seppi K. MRI for the differential diagnosis of neurode-generative parkinsonism in clinical practice // Parkinsonism Relat. Disord. — 2007. — Vol. 13, suppl. 3. — P. 400–405.
20. Труфанов Г.Е., Тютин Л.А. Магнитно-резонансная спектроскопия // Рук-во для врачей. — СПб.: ЭЛБИ-СПб, 2008. — 50 с. / Trufanov G.E., Tyutin L.A. Magnetic resonance spectroscopy // Textbook for physicians. — St Petersburg: ALBY-SPb, 2008. — 50 p. [Russian].
21. Birkenhager W.H., Staessen J.A. Progress in cardiovascular diseases: cognitive function in essential hypertension // Prog. Cardiovasc. Dis. — 2006. — Vol. 49, № 1. — P. 1–10.
22. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specifi c expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro // J. Neurochem. — 1992. — Vol. 59, № 1. — P. 55–61.
23. Jung R.E., Yeo R.A., Chiulli S.J., Sibbitt W.L., Brooks W.M. Myths of neuropsychology: Intelligence, neurometabolism, and cognitive ability // Clin. Neuropsychol. — 2000. — Vol. 14, № 4. — Р. 535–545.
24. Brooks W.M., Friedman S.D., Gasparovic C. Magnetic resonance spectroscopy in traumatic brain injury // J. Head Trauma Rehabil. — 2001. — Vol. 16, № 2. — Р. 149–164.
25. Clarke C.E., Lowry M. Systematic review of proton mag-netic resonance spectroscopy of the striatum in parkinsonian syndromes // Eur. J. Neurol. — 2001. — Vol. 8, № 6. — Р. 573–577.
26. Valenzuela M.J., Sachdev P. Magnetic resonance spectroscopy in AD // Neurology. — 2001. — Vol. 56, № 5. — Р. 592–598.
27. Маршалл В.Д. Клиническая биохимия. — М.-СПб.: Бином-«Невский диалект», 1999. — 368 с. / Marshall E. Clinical biochemistry. — Moscow-St Petersburg: Binom-the «Nevsky dialect», 1999. — 368 p. [Russian].
28. Неронов Ю.И. Ядерный магнитный резонанс в томографии и в спектральных исследованиях. — СПб.: СПб ГИТМО (ТУ), 2003. — 104 с. / Neronov Y.I. Nuclear magnetic resonance imaging and spectral studies // St Petersburg: St Petersburg GITMO (TU), 2003. — 104 p. [Russian].
29. Bohnen N.I., Kaufer D.I., Ivanco L.S. et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study // Arch. Neurol. — 2003. — Vol. 60, № 12. — P. 1745–1748.
30. Molina J.A., Garcia-Segura J.M., Benito-Leon J. et al. Proton magnetic resonance spectroscopy in dementia with Lewybodies // Eur. Neurol. — 2002. — Vol. 48, № 3. — P. 158–163.
31. Ricci P.E. Proton MR spectroscopy in ischemic stroke and others vascular disorders in proton MR spectroscopy of the brain // Neuroimag. Clin. North Am. — 1998. — Vol. 8, № 4. — P. 881–900.
32. Wang Z., Zhao C., Yu L., Zhou W., Li K. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease // Acta Radiol. — 2009. — Vol. 50, № 3. — P. 312–319.
33. Хухо Ф. Нейрохимия: основы и принципы. — М.: Мир, 1990. — 398 с. / Khukho F. Neurochemistry: fundamentals and principles. — Мoscow: Peace [Mir], 1990. — 398 p. [Russian].
34. Herminghaus S. Vascular dementia: patohologic neurochemistry and improved diagnosis assessed by proton MR spectroscopy // Presented at the 39th annual meeting of the American Society of Neuroradiology. — Boston. — April 2001.
35. Tong T., Zhenwei Y., Xiaoyuan F. 1Н-MR spectroscopy changes in transient ischemic attack patients and their correlation with perfusion-weighted imaging // Int. J. Neurosci. — 2010. — Vol. 120, № 9. — 596–601.
36. Mason G.F., Pan J.W., Ponder S.L., Twieg D.B., Pohost G.M., Hetherington H.P. Detection of brain glutamate and glutamine in spectroscopic images at 4.1T // Magn. Reson. Med. — 1994. — Vol. 32, № 1. — P. 142–145.
37. Березов Т.Т. Биологическая химия. — М.: Медицина, 1998. — 704 с. / Berezov T.T. Biological chemistry. — Moscow: Medicine, 1998. — 704 p. [Russian].
38. Martínez-Bisbal M.C., Arana E., Martí-Bonmatí L., Mollá E., Celda B. Cognitive impairment: classifi cation by 1H magnetic resonance spectroscopy // Eur. J. Neurol. — 2004. — Vol. 11, № 3. — P. 187–193.
39. Fayed N., Dávila J., Oliveros A., Castillo J., Medrano J. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia // J. Acad. Radiol. — 2008. — Vol. 15, № 9. — Р. 1089–1098.
40. Modrego P.J., Fayed N., Sarasa M. Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study // Br. Med. J. Open. — 2011. — Vol. 1, № 1. — Р e000007.
41. Foy C.M., Daly E.M., Glover A. et al. Hippocampal proton MR spectroscopy in early Alzheimer’s disease and mild cognitive impairment // Brain Topogr. — 2011. — Vol. 24, № 3–4. — Р. 316–322.
42. Bakker F.C., Klijn C.J., Jennekens-Schinkel A. et al. Cognitive impairment is related to cerebral lactate in patients with carotid artery occlusion and ipsilateral transient ischemic attacks // Stroke. — 2003. — Vol. 34, № 6. — P. 1419–1424.
43. Klijn C.J.M., Kappelle L.J., van der Grond J., Algra A., Tulleken C.A.F., van Gijn J. Magnetic resonance techniques for the identifi cation of patients with symptomatic carotid artery occlusion at high risk of cerebral ischemic events // Stroke. — 2000. — Vol. 31, № 12. — P. 3001–3007.
44. Mao-Shin Lin M., Chiu M., Wu Y. et al. Neurocognitive improvement after carotid artery stenting in patients with chronic internal carotid artery occlusion and cerebral ischemia // Stroke. — 2011. — Vol. 42, № 10. — P. 2850–2854.
Review
For citations:
Zueva I.B., Moroshkina N.V., Barantsevich E.R., Trufanov G.E. MAGNETIC RESONANCE SPECTROSCOPY IN EVALUATION OF COGNITIVE FUNCTIONS IN PATIENTS WITH METABOLIC SYNDROME. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2013;19(1):51-58. (In Russ.) https://doi.org/10.18705/1607-419X-2013-19-1-51-58
Views:
1388
Email this article 